Kynam Capital Management, LP Portfolio Holdings

Kynam Capital Management, LP

  • $1.22 Billion
  • Q3 2024

Kynam Capital Management, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.22 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $260M, Vaxcyte, Inc. with a value of $119M, Celldex Therapeutics, Inc. with a value of $117M, Syndax Pharmaceuticals Inc with a value of $112M, and Cogent Biosciences, Inc. with a value of $99.8M.

Examining the 13F form we can see an decrease of $65.7M in the current position value, from $1.28B to 1.22B.

Kynam Capital Management, LP is based out at Princeton, NJ

Below you can find more details about Kynam Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.22 Billion
Healthcare: $1.22 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$16.5B
$260 Million 21.3% of portfolio
2,042,471
Q3 2024 Added 1.39%
$5.43B
$119 Million 9.73% of portfolio
1,039,288
Q3 2024 Added 37.98%
$1.27B
$117 Million 9.64% of portfolio
3,458,609
Q3 2024 Added 2.05%
$945M
$112 Million 9.23% of portfolio
5,842,925
Q3 2024 Added 2.11%
$623M
$99.8 Million 8.19% of portfolio
9,239,731
Q3 2024 Reduced 0.22%
$1.65B
$92.8 Million 7.62% of portfolio
8,332,687
Q3 2024 Added 17.65%
$1.34B
$69.7 Million 5.72% of portfolio
1,576,549
Q3 2024 Added 2.13%
$1.37B
$69 Million 5.66% of portfolio
9,085,368
Q3 2024 Added 2.93%
$838M
$57.1 Million 4.69% of portfolio
2,511,295
Q3 2024 Added 43.5%
$1.33B
$40.2 Million 3.3% of portfolio
4,899,497
Q3 2024 Added 23.24%
$1.99B
$31.9 Million 2.62% of portfolio
1,302,085
Q3 2024 New
$151M
$28.1 Million 2.31% of portfolio
5,953,825
Q3 2023 Added 21.74%
$723M
$22.7 Million 1.86% of portfolio
2,266,328
Q3 2024 Added 147.26%
$2.12B
$20.5 Million 1.68% of portfolio
456,369
Q3 2024 Reduced 42.95%
$1.26B
$19.2 Million 1.57% of portfolio
1,371,511
Q3 2024 Reduced 32.16%
$555M
$15.1 Million 1.24% of portfolio
3,685,563
Q3 2024 Added 124.47%
$214M
$7.82 Million 0.64% of portfolio
12,414,628
Q3 2024 Added 2.13%
$143M
$7.15 Million 0.59% of portfolio
2,066,447
Q3 2024 Added 2.11%
$144M
$4.59 Million 0.38% of portfolio
2,356,147
Q3 2024 Added 43.08%
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 3,184.68%
Burning Rock Biotech LTD
-
$0 0.0% of portfolio
-
Q3 2024 Added 1.49%
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 1.93%
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $1.22 Billion
  • Prior Value $1.28 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 2 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email